LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,069 | -72.6% | 21,164 | -42.5% | 0.00% | – |
Q2 2023 | $84,328 | +125.9% | 36,825 | +139.7% | 0.00% | – |
Q1 2023 | $37,332 | +1766.6% | 15,363 | +1918.8% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 761 | -42.7% | 0.00% | – |
Q2 2022 | $2,000 | -99.5% | 1,327 | -99.3% | 0.00% | – |
Q1 2022 | $376,000 | -80.6% | 179,952 | -63.5% | 0.00% | – |
Q4 2021 | $1,941,000 | -27.0% | 492,731 | -10.9% | 0.00% | -100.0% |
Q3 2021 | $2,660,000 | +97.5% | 552,963 | +88.5% | 0.00% | – |
Q2 2021 | $1,347,000 | +372.6% | 293,408 | +503.7% | 0.00% | – |
Q1 2021 | $285,000 | +44.7% | 48,600 | -15.5% | 0.00% | – |
Q4 2020 | $197,000 | -8.8% | 57,487 | -61.7% | 0.00% | – |
Q3 2020 | $216,000 | -0.5% | 150,093 | +38.1% | 0.00% | – |
Q2 2020 | $217,000 | +2.4% | 108,667 | +0.2% | 0.00% | – |
Q1 2020 | $212,000 | -28.9% | 108,461 | +50.6% | 0.00% | – |
Q4 2019 | $298,000 | +351.5% | 71,996 | +226.7% | 0.00% | – |
Q3 2019 | $66,000 | -49.6% | 22,037 | +5.7% | 0.00% | – |
Q2 2019 | $131,000 | -7.1% | 20,844 | -17.5% | 0.00% | – |
Q1 2019 | $141,000 | -16.6% | 25,252 | -0.3% | 0.00% | – |
Q4 2018 | $169,000 | -37.6% | 25,337 | -0.3% | 0.00% | – |
Q3 2018 | $271,000 | -10.0% | 25,401 | +1.2% | 0.00% | – |
Q2 2018 | $301,000 | -23.4% | 25,101 | -45.3% | 0.00% | – |
Q1 2018 | $393,000 | -26.5% | 45,924 | -15.2% | 0.00% | – |
Q4 2017 | $535,000 | -61.4% | 54,156 | -52.0% | 0.00% | – |
Q3 2017 | $1,385,000 | -5.0% | 112,721 | +27.2% | 0.00% | – |
Q2 2017 | $1,458,000 | +4.8% | 88,590 | -8.7% | 0.00% | – |
Q1 2017 | $1,391,000 | -9.0% | 97,024 | -12.3% | 0.00% | -100.0% |
Q4 2016 | $1,529,000 | -60.5% | 110,584 | -48.3% | 0.00% | 0.0% |
Q3 2016 | $3,868,000 | +268.7% | 214,057 | +192.8% | 0.00% | – |
Q2 2016 | $1,049,000 | +16.0% | 73,104 | -3.4% | 0.00% | – |
Q1 2016 | $904,000 | +326.4% | 75,650 | +374.6% | 0.00% | – |
Q4 2015 | $212,000 | -19.7% | 15,939 | -35.1% | 0.00% | – |
Q3 2015 | $264,000 | +116.4% | 24,566 | +62.4% | 0.00% | – |
Q2 2015 | $122,000 | – | 15,127 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |